BMC Pediatrics · 2017 · 10 citations · 18 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsPediatric GeneticsBone DysplasiasDysplasiaGenetic DisordersGenetic SyndromesRare Disease GeneticsSkeletal DysplasiasClinical Genetic DiagnosisDisease PrognosisMild DysplasiaMutationOsseous DysplasiaShort Stature AssessmentShort Stature GeneticsSpondyloepimetaphyseal Dysplasia
BACKGROUND: Schimke immune-osseous dysplasia (SIOD, OMIM 242900) is characterized by spondyloepiphyseal dysplasia, T-cell deficiency, renal dysfunction and special facial features. SMARCAL1 gene mutations are determined in approximately 50% of patients diagnosed with SIOD. CASE PRESENTATION: The case presented here is that of a 6-year-old boy who was born at 33 weeks to healthy, non-consanguineous Chinese parents. He presented with short stature (95 cm; <3rd percentile) and proteinuria. Initially suspected of having IgM nephropathy, the patient was finally diagnosed with mild Schimke immune-osseous dysplasia. One novel mutation (p.R817H) and one well-known mutation (p.R645C) was identified in the SMARCAL1 gene. CONCLUSION: This report describes a clinical and genetic diagnostic model of mild SIOD. It also highlights the importance of molecular testing or clinical diagnosis and the guidance it provides in disease prognosis.
18
Alexander E. Gorbalenya, Eugene V. Koonin, Alexei P. Donchenko et al. · Nucleic Acids Research · 1989 · 1K citations · Full text